TREATMENTS for gastric cancer
There are five different types of standard treatment available for patients with gastric cancer: surgery, chemotherapy, radiotherapy, chemoradiation, targeted therapy directed against HER2.
New types of treatment are being investigated in clinical trials: immunotherapy & therapies directed against molecular targets.
Between 20 and 30% of gastric cancer patients have overexpression (increased activity) of the epidermal growth factor receptor 2 (HER2) gene. For these patients, personalized treatment combined with chemotherapy has been shown to significantly improve survival.
Our Molecular Biology Laboratory performs complex analyses of HER2 overexpression, as well as studying other genetic biomarkers that allow us to tailor therapy to each patient, thus increasing the chances of successful treatment. Specific treatments for gastric cancer, such as Trastuzumab (Herceptin®), are available in our centers.